BioXtreme
PrivateLast Round
Strategic
Apr 21, 2026
Total Funding Raised
$14.57M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioXtreme is a medical device company that develops robotic rehabilitation systems for patients recovering from strokes, traumatic brain injuries, and other neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioXtreme Comparables
Compare BioXtreme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionik Laboratories Corp. | 81% | |
| DIH Medical | 81% | |
| Bioventus | 77% |
BioXtreme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 21, 2026 | ||||
| Crowdfunding | Sep 1, 2023 | ||||
| VC Round | Aug 1, 2019 | ||||
| Seed | Nov 1, 2011 | ||||
| Accelerator | May 1, 2010 |
BioXtreme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| ExitValley | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
$9.3M raised in a strategic round.
- Nov 1, 2011
$5M round with Israel Innovation Authority
BioXtreme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioXtreme's valuation, stock price, and market status.
Is BioXtreme a public or private company?
BioXtreme is a private company.
What is the current stock price of BioXtreme?
BioXtreme is a private company with no public stock price. No recent secondary market data is available.
How much is BioXtreme worth (valuation)?
Valuation information for BioXtreme is not publicly available.
Can I buy BioXtreme stock?
BioXtreme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioXtreme's last funding round?
BioXtreme's most recent funding round was Strategic on April 21, 2026.
Who are the main investors in BioXtreme?
Key investors in BioXtreme include ExitValley.
Will BioXtreme IPO soon?
No public IPO plans have been announced for BioXtreme.
How can I track BioXtreme secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioXtreme's secondary market activity and sign up for updates.